[Retracted] Circulating Levels of IL-13, TGF-β1, and Periostin as Potential Biomarker for Coronary Artery Disease with Acute Heart Failure

Table 1

Baseline characteristics among control, CAD, and AHF groups.

Baseline characteristic	AHF (n = 83)	CAD (n = 52)	Control (n = 52)
Gender (male/%)	55 (66.27%)	34 (65.38%)	34 (65.38%)	0.992
Age (year)	64.34 ± 5.17	63.06 ± 4.30	63.42 ± 3.98	0.254
Body mass index (kg/m^2)	22.77 ± 2.99	22.49 ± 2.62	22.28 ± 2.09	0.571
Smoking status (%)	54 (65.06%)	32 (61.54%)	31 (59.62%)	0.804
HR (time/min)	83.04 ± 12.53	83.23 ± 10.75	83.88 ± 11.06	0.918
ALT (U/L)	25.25 ± 9.93	25.00 ± 8.64	24.91 ± 8.71	0.976
AST (U/L)	24.88 ± 9.57	24.08 ± 9.75	23.64 ± 7.14	0.722
Creatinine (μmol/L)	94.14 ± 24.17	93.61 ± 22.58	93.43 ± 20.55	0.982
BUN (mmol/L)	5.49 ± 1.79	5.40 ± 1.33	5.33 ± 1.13	0.830
LVEF (%)	42.40 ± 4.79^#	52.94 ± 4.23	60.83 ± 4.52	<0.001
LVEDD (mm)	58.33 ± 2.24^#	55.59 ± 2.25	51.01 ± 1.99	<0.001
LVEDV (ml)	229.47 ± 29.66^#	197.99 ± 31.28	97.97 ± 18.66	<0.001
LVMI (g/m^2)	133.06 ± 15.05^#	124.07 ± 14.81	104.10 ± 11.20	<0.001

Note: HR, heart rate; SBP, systolic blood pressure; DBP, diastolic blood pressure; ALT, alanine aminotransferase; AST, aspartate aminotransferase; BUN, blood urea nitrogen; compared to the control group; and ^# compared to the CAD group.